Chrysophanol and islandicin, two anthraquinones which are structurally related to emodin, were found to be frame-shift mutagens for Salmonella typhimurium strain TA 1537 after metabolic activation.
Chrysophanol and islandicin, two anthraquinones which are structurally related to emodin, were found to be frame-shift mutagens for Salmonella typhimurium strain TA 1537 after metabolic activation.
Emodin, chrysophanol, and islandicin are simple substituted anthraquinones which have been isolated as mold metabolites (9) . Emodin, a diarrheagenic toxin (14) produced by several fungal species (7, 8) , has been shown to be a frame-shift mutagen in the Ames/Salmonella assay (13) . In their study of twelve anthraquinone and dianthraquinone mycotoxins, Stark et al. (11) evaluated the mutagenicity of islandicin and chrysophanol. Only two (TA 98 and TA 100) of the recommended five Ames tester strains were used. None of these twelve mycotoxins induced the reversion of histidine auxotrophs to prototrophy. In a parallel series of tests, these investigators assayed these mycotoxins for mutagenic activity in the 8-azaguanine forward-mutation assay described by Skopek et al. (10) . Emodin, islandicin, and chrysophanol were nonmutagens in this test.
Because Wehner et al. (13) reported that emodin was mutagenic when tested against TA 1537, we decided to reevaluate the mutagenic activity of the structurally related compounds islandicin and chrysophanol (Fig. 1) .
In this paper, we report that these two compounds are in fact mutagenic and that, as Wehner et al. (13) have reported for emodin, this activity was observed after metabolic activation against TA 1537.
MATERIALS AND METHODS
Mycotoxins. Emodin, chrysophanol, and islandicin were isolated by methods described earlier (7, 8 
RESULTS
Mutagenic activity was observed in the presence of the metabolic activation system (S9) against strain TA 1537. The order of decreasing mutagenicity was emodin, chrysophanol, and islandicin. The three anthraquinones did not induce histidine reversion in the other four strains tested ( Table 1 ). The mutagenic activity of chrysophanol and islandicin ( Fig. 2 ) was demonstrated with the quantitative Ames test. The qualitative disk diffusion assay was negative (data not shown). The three test substances were not toxic to the Salmonella strains (no zones of inhibition were observed).
DISCUSSION
Our results confirm the report of Wehner et al. (13) that emodin is a frame-shift mutagen which requires metabolic activation. We have also demonstrated that islandicin and chrysophanol, which are structurally related to emodin, are also frame-shift mutagens for TA 1537 after metabolic activation.
In addition, our results illustrate two basic principles to be considered in evaluation of potential mutagens in bacterial assays. First, it is essential that the five recommended Ames strains (6) be used for screening substances. Sec Chrysophanol and islandicin require S9 activation before the expression of mutagenic activity. Although the activated forms for these (as well as emodin) are unknown at present, the structural relatedness of these anthraquinones does suggest some relationship of mutagenicity.
Emodin and islandicin differ in the position of a single hydroxyl (OH) group. The placement of the OH at position 6 (Fig. 1) gives rise to emodin, which is the most mutagenic of the three. Islandicin, which is the least mutagenic, has an OH group at position 4. Chrysophanol, which possesses intermediate mutagenic activity, is missing this third OH group (at position 4 or 6).
Our present feeling is that the metabolically activated dihydroxyanthraquinone structure (i.e., activated chrysophanol) is the fundamental mutagenic unit. The presence of the OH at position 6 (emodin) facilitates either the formation of the mutagen or the interaction between the activated mutagen and the target. The placement of an OH group at position 4 (islandicin) may either restrict the formation of the activated species or sterically hinder the interaction between the activated structure and the target and thereby reduce mutagenic activity. We are presently preparing a series of modified structures to determine if the above hypothesis is valid.
